Tradingview
Published November 16, 2026
Saniona receives FDA clearance to initiate Phase 1 of SAN2465 - TradingView
Read the full story at Tradingview
Our ambition is to deliver rapid antidepressant efficacy comparable to ketamine and esketamine in an oral treatment that patients could take at home.
Surfaced by this Google Alert
- Ketamine